Sort by
Refine Your Search
-
clinical trial of the aldosterone synthase inhibitor in patients with chronic kidney disease treated with empagliflozin) is a large international investigator-initiated study, run through University
-
with chronic kidney disease treated with empagliflozin) is a large international investigator-initiated study, run through University of Oxford and sponsored by Boehringer Ingelheim. This position is
-
study, run through University of Oxford and sponsored by Boehringer Ingelheim. This position is for a Research Coordinator to be part of the Regional Coordinating Centre (RCC) team in Canada. Under
Enter an email to receive alerts for Education "University of Oxford " positions